Morepen Laboratories secures NMPA approval for Loratadine API in China
The company expands its global footprint with regulatory approval from China’s NMPA, reinforcing its leadership in antihistamine…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
active pharmaceutical ingredient (API)
Motilal Oswal Alternates invests up to INR 460 crores for majority stake in Megafine
The Sanghvi family increases its stake in Megafine as part of the transaction
USFDA classifies inspection at Dr Reddy’s API facility as Voluntary Action Indicated
Dr Reddy’s Laboratories receives Establishment Inspection Report for its API manufacturing facility in Bollaram, Hyderabad
Orchid Pharma completes USFDA inspection at Alathur API facility with seven minor observations
The facility remains India’s only USFDA-approved site for Sterile Cephalosporins and secures EU GMP certification renewal
India Ratings and Research maintains Neutral Outlook for pharmaceuticals sector in FY26
Revenue growth projected at 9 % -10 % year-on-year; operating margins expected to remain stable
Wanbury receives CEP certification for Dextromethorphan API from EDQM
Certification enables Wanbury to begin commercial sales of Dextromethorphan API in European markets